date,title,source
Oct-22-18,Theravance Biopharma Reports Data from TD-1473 Phase 1b Four-Week Study in Oral Late-Breaker Presentation at UEG Week 2018,PR Newswire
Oct-30-18,Theravance Biopharma (TBPH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
Oct-30-18,Theravance Biopharma to Report Third Quarter 2018 Financial Results on November 6,PR Newswire
Nov-06-18,"Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-06-18,Theravance Bio: 3Q Earnings Snapshot,Associated Press
Nov-06-18,"Theravance Biopharma, Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update",PR Newswire
Nov-07-18,Theravance Biopharma to Present at the Credit Suisse 27th Annual Healthcare Conference,PR Newswire
Nov-07-18,Edited Transcript of TBPH earnings conference call or presentation 6-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-08-18,"Theravance (TBPH) Beats on Q3 Earnings, Inks Deal for Vibativ",Zacks
Nov-09-18,Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease,PR Newswire
Nov-09-18,Mylan and Theravance Biopharma's COPD treatment gets FDA approval,Reuters
Nov-12-18,"Health Care Digest: A big Berkeley bio incubator, Apple's clinical trial help and more",American City Business Journals
Nov-12-18,Theravance Biopharma Highlights Expanded COPD Indication for Trelegy Ellipta in Europe,PR Newswire
Nov-14-18,"New Research Coverage Highlights Nexa Resources S.A, Qumu, Clearway Energy, Vermillion, Cantel Medical, and Theravance Biopharma  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-19-18,Theravance Biopharma to Present at Two Upcoming Investor Conferences,PR Newswire
Nov-20-18,IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses,Investor's Business Daily
Nov-20-18,Theravance Biopharma Announces First Patient Dosed in Phase 2 Study of TD-1473 in Patients with Crohn's Disease,PR Newswire
Nov-21-18,Theravance JAK Inhibitor Enters Phase II for Crohn's Disease,Zacks
Nov-27-18,"Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor",PR Newswire
Nov-28-18,Theravance's Respiratory Disease JAK Inhibitor Enters Phase I,Zacks
Nov-29-18,"Theravance Pipeline Strong, Plans Yupelri Launch by Year End",Zacks
Dec-03-18,Theravance Biopharma Announces Closing of Private Placement of $250 Million of 9% Non-Recourse Notes,PR Newswire
Dec-04-18,Theravance Biopharma to Highlight Innovative Early Research and Clinical Development at R&D Day on December 12 in New York,PR Newswire
Jan-07-19,Theravance Biopharma Announces Alignment of Workforce with Focus on Key Strategic Priorities,PR Newswire
Jan-08-19,"Should You Worry About Theravance Biopharma, Inc.s (NASDAQ:TBPH) CEO Pay Cheque?",Simply Wall St.
Jan-23-19,"With $500M in reserve, biotech cuts 49 jobs to focus on maturing drug pipeline",American City Business Journals
Jan-28-19,Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension,PR Newswire
Feb-19-19,"/C O R R E C T I O N -- Theravance Biopharma, Inc./",PR Newswire
Feb-19-19,Will Leasing Support SBA Communications' (SBAC) Q4 Earnings?,Zacks
